Titan Medical (Nasdaq: TMDI; TSX: TMD) expects manufactured units of the Enos robotic-assisted surgery system will be available later this year. The goal is to commercially launch Enos in early 2025 after securing a De Novo market authorization from the FDA, the Toronto-based robotic surgery company said during its second-quarter earnings report today. Titan Medical […]
Robotic Surgery
Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
Levita Magnetics said today it has raised $26 million to fund regulatory and commercial progress on its Magnetic-Assisted Robotic Surgery (MARS) platform. The Menlo Park, California-based robotic surgery system developer also appointed Maria Sainz as chair of its board of directors. The MARS platform is designed to help surgeons perform more high-volume abdominal procedures using […]
Stereotaxis stock down amid cloudy outlook
Stereotaxis (NYSE: STXS) today reported second-quarter revenue that missed Wall Street projections, with the surgical robotics company unable to say how quickly revenue will pick up. Investors reacted by sending STXS shares down more than 18% to $2.10 apiece by late afternoon trading today. The St. Louis–based company lost $5.1 million, or 7¢ per share, […]
Vicarious Surgical completes Beta 2 system design
Vicarious Surgical (NYSE:RBOT) continues to progress in the development of its Beta 2 robotic surgery platform, though supply chain disruption poses risks for the company’s timeline. That appeared to be the big message out of the Waltham, Massachusetts–based surgical robotics company’s Q2 earnings report yesterday evening. Vicarious Surgical’s technology uses proprietary human-like surgical robots combined […]
Asensus Surgical says procedures up by more than a third in Q2
Asensus Surgical (NYSE American: ASXC) today announced mixed Q2 results that also included 34% procedures growth year-over-year. The Research Triangle Park, North Carolina–based surgical robotics and digital surgery company lost $19.6 million, or 8¢ per share, off $994,000 in revenue for the quarter ended June 20, 2022 — versus a loss of $13.2 million, or […]
Medical Microinstruments raises $75M for robotic microsurgery
Robotic microsurgery company Medical Microinstruments announced today that it raised $75 million in a Series B financing round. Pisa, Italy–based Medical Microinstruments plans to use proceeds from the financing round, along with its planned U.S. presence, to move into its next stage of growth through expanded indications and ongoing commercialization efforts for its Symani microsurgery […]
Nasdaq grants Titan Medical 180-day extension to regain compliance
Titan Medical (Nasdaq:TMDI) announced today that it received an additional 180 days to regain compliance with the Nasdaq market. According to a news release, the Listing Qualifications Staff of The Nasdaq Stock Market notified the company that it received 180 extra calendar days — running through Dec. 26, 2022 — to evidence compliance with the […]
Memic completes first robotic-assisted transvaginal hysterectomy procedures with Hominis
Memic Innovative Surgery announced today that the first U.S. patient procedures were completed with its Hominis system for robotic-assisted transvaginal hysterectomy. HCA Florida Kendall Hospital and The Women’s Hospital at Jackson Memorial successfully completed the first U.S. patient procedures using Hominis, the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, […]
‘Multiple disruptions’ slow timeline for Titan Medical’s Enos robotic surgery platform
Titan Medical (Nasdaq:TMDI) announced today that it updated the FDA submission timeline for its Enos robotic surgery platform. “Multiple disruptions” have resulted in an updated FDA investigational device exemption (IDE) submission timeline for the Enos robotic single access surgery system, with the Toronto-based company now expecting the IDE submission to come in mid-2023, rather than […]
Moon Surgical raises $31.3M for robotic surgery system
Moon Surgical (Paris and San Francisco) announced today that it has raised $31.3 million in Series A funding to expand its team and accelerate the development of its Maestro robotic surgery system. GT Healthcare Capital & Partners led the round. There was also participation from Johnson & Johnson Innovation – JJDC, Cathay Health — and […]
Creo Medical inks collaboration agreement with Intuitive
Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems. The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday […]